Evidence map›Paper›PMID 40649854›Full record

ReviewInternational journal of molecular sciences2025

The Role of Microbiota in the Pathogenesis of Bullous Pemphigoid and Pemphigus Vulgaris: Evidence, Controversies, and Perspectives.

Francesca Gorini, Alessio Coi, Michele Santoro, Alessandro Tonacci, Francesco Sansone, Elena Biancamaria Mariotti, Marta Donati, Alice Verdelli, Maria Rita Nasca, Paolo Amerio and 3 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesca GoriniUnit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0002-4619-6227
Alessio CoiUnit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0002-9816-3144
Michele SantoroUnit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.
Alessandro TonacciInformation Systems Unit, Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0001-8335-5541
Francesco SansoneInformation Systems Unit, Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.
Elena Biancamaria MariottiDepartment of Health Sciences, Section of Dermatology, Azienda USL Toscana Centro, University of Florence, 50122 Florence, Italy.ORCID 0000-0003-0388-1037
Marta DonatiDepartment of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, 50122 Florence, Italy.
Alice VerdelliDepartment of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, 50122 Florence, Italy.ORCID 0000-0003-1982-888X
Maria Rita NascaDermatology Clinic, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-7107-9487
Paolo AmerioDermatologic Clinic, G. D'Annunzio University, 66100 Chieti, Italy.ORCID 0000-0003-1589-9672
Emiliano AntigaDepartment of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, 50122 Florence, Italy.ORCID 0000-0001-7787-4433
Emanuela BarlettaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", Experimental Pathology and Oncology Section, University of Florence, 50134 Firenze, Italy.ORCID 0000-0001-7493-1498
Marzia CaproniDepartment of Health Sciences, Section of Dermatology, University of Florence, P. Palagi Hospital, 50122 Florence, Italy.ORCID 0000-0002-7471-3471

Funding

European Union D13C22002810006
6 · The paper itself

Abstract

Bullous pemphigoid (BP) and pemphigus vulgaris (PV) represent the most prevalent conditions among autoimmune bullous skin diseases, considered a major cause of severe morbidity and, in certain cases, mortality. The hallmark of the two diseases is the presence of autoantibodies directed against proteins located in the basement membrane of the skin, which determines the formation of blisters. In recent years, interest in the role of microbiota in relation to health-disease status has progressively increased. In particular, based on the gut-skin axis, accumulating evidence has emerged on the potential association between the composition and diversity of microbial communities in the gut, skin, and even in the oral cavity and the risk of developing BP and PV. Dysbiosis, characterized by a generally higher relative abundance of Firmicutes and a depletion of probiotics/beneficial species, might contribute to the pathogenesis of both diseases. Despite the still limited number of studies and the need for further large-scale multicenter studies, the knowledge gathered so far is suggestive of a novel modifiable risk factor representing a potential target for adjuvant treatments of these disabling and life-threatening conditions.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaPemphigoid, BullousPemphigusAnimalsDysbiosisHumansSkinautoimmune bullous skin diseasesbullous pemphigoidgut microbiotaoral microbiotapemphigus vulgarisprobioticsskin microbiota

Identifiers

PMID40649854
PMCPMC12249555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.